Olema Oncology Insider Trades
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 25 · $24.74M
- Shares bought / sold
- 0 / 880.50K
- Net activity
- Net selling $24.7 million
Olema Oncology insider activity
Over the last 12 months, Olema Oncology insiders reported 43 transactions on SEC Form 4: 0 open-market purchases and 25 sales. Insiders bought $0 and sold $24.7 million worth of stock, for net insider selling of $24.7 million. The largest seller was CLARK IAN T, with $7.9 million in reported sales.
The most recent filing shows Harmon Cyrus (Director) selling 12,500 shares at $11.71 on Jul 24, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OLMA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OLMA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 24, 2026 | Harmon CyrusDirector | Sale | 12,500 | $146.43K | Form 4 |
| Jul 23, 2026 | Harmon CyrusDirector | Sale | 12,500 | $144.74K | Form 4 |
| Mar 4, 2026 | Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 233 | $5.75K | Form 4 |
| Mar 4, 2026 | Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 24,767 | $600.60K | Form 4 |
| Mar 4, 2026 | Mitchell ShawnteCHIEF LEGAL OFFICER | Option exercise | 25,000 | $109.25K | Form 4 |
| Mar 3, 2026 | Mitchell ShawnteCHIEF LEGAL OFFICER | Sale | 15,000 | $345.15K | Form 4 |
| Mar 3, 2026 | Mitchell ShawnteCHIEF LEGAL OFFICER | Option exercise | 15,000 | $65.55K | Form 4 |
| Feb 2, 2026 | Austin Sasha LuVP of Finance and Controller | Award | 11,700 | — | Form 4 |
| Jan 20, 2026 | Harmon CyrusDirector | Sale | 10,000 | $268.80K | Form 4 |
| Jan 15, 2026 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Sale | 100,000 | $2.87M | Form 4 |
| Jan 14, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 35,003 | $1.01M | Form 4 |
| Jan 14, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 14,997 | $428.91K | Form 4 |
| Jan 14, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Option exercise | 50,000 | $243.50K | Form 4 |
| Jan 14, 2026 | Harmon CyrusDirector | Sale | 3,489 | $101.60K | Form 4 |
| Jan 13, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 200 | $5.70K | Form 4 |
| Jan 13, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 49,800 | $1.37M | Form 4 |
| Jan 13, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Option exercise | 50,000 | $243.50K | Form 4 |
| Jan 13, 2026 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Sale | 3,822 | $107.05K | Form 4 |
| Jan 12, 2026 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 10,000 | $283.40K | Form 4 |
| Dec 26, 2025 | Bohen SeanPresident and CEO | Gift | 8,500 | — | Form 4 |
| Dec 23, 2025 | Zojwalla NaseemChief Medical Officer | Sale | 99,509 | $2.75M | Form 4 |
| Dec 23, 2025 | Zojwalla NaseemChief Medical Officer | Option exercise | 50,000 | $351.00K | Form 4 |
| Dec 22, 2025 | Zojwalla NaseemChief Medical Officer | Sale | 100,000 | $2.80M | Form 4 |
| Dec 22, 2025 | Zojwalla NaseemChief Medical Officer | Option exercise | 7,182 | $50.42K | Form 4 |
| Dec 22, 2025 | Zojwalla NaseemChief Medical Officer | Option exercise | 42,818 | $652.97K | Form 4 |
| Dec 22, 2025 | Harmon CyrusDirector | Sale | 2,881 | $82.19K | Form 4 |
| Dec 19, 2025 | Zojwalla NaseemChief Medical Officer | Sale | 12,921 | $373.80K | Form 4 |
| Dec 19, 2025 | Zojwalla NaseemChief Medical Officer | Sale | 57,079 | $1.60M | Form 4 |
| Dec 19, 2025 | Zojwalla NaseemChief Medical Officer | Option exercise | 40,000 | $610.00K | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Sale | 41,840 | $1.28M | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Sale | 193,056 | $5.74M | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Sale | 29,904 | $862.13K | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Option exercise | 12,070 | $49.25K | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Option exercise | 21,520 | $168.72K | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Option exercise | 21,520 | $77.69K | Form 4 |
| Dec 19, 2025 | CLARK IAN TDirector | Option exercise | 209,690 | $923.89K | Form 4 |
| Dec 19, 2025 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Gift | 9,000 | — | Form 4 |
| Dec 19, 2025 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 6,046 | $189.78K | Form 4 |
| Dec 19, 2025 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 43,729 | $1.33M | Form 4 |
| Dec 19, 2025 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | Sale | 1,225 | $34.40K | Form 4 |
| Dec 8, 2025 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Gift | 75,000 | — | Form 4 |
| Nov 26, 2025 | Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF. | Gift | 225,000 | — | Form 4 |
| Nov 25, 2025 | RAPPAPORT ANDREWDirector | Gift | 35,868 | — | Form 4 |
| Nov 21, 2025 | RAPPAPORT ANDREWDirector | Option exercise | 35,868 | $13.99K | Form 4 |
| Sep 18, 2025 | Harmon CyrusDirector | Sale | 3,086 | $25.68K | Form 4 |
| Sep 18, 2025 | Harmon CyrusDirector | Sale | 10,000 | $83.30K | Form 4 |
| Sep 16, 2025 | Harmon CyrusDirector | Sale | 1,914 | $15.47K | Form 4 |
| Sep 16, 2025 | Harmon CyrusDirector | Sale | 10,000 | $80.40K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4